Insights
Explore the latest insights in chemical proteomics, target engagement, and drug discovery. Read scientific perspectives, research updates, and company news from our team.
Chemical Proteomics in Drug Discovery: Better Target-Engagement Decisions
Chemical proteomics helps drug discovery teams understand how small molecules interact with proteins in biologically relevant systems. By measuring cellular target engagement and selectivity across many endogenous proteins at the same time, it can reveal whether a...
Chemical Proteomics in Drug Discovery: Better Target-Engagement Decisions
Learn how chemical proteomics measures cellular target engagement and selectivity to support candidate prioritisation during drug discovery.
Target Engagement Profiling
Target Engagement Profiling helps drug discovery teams understand whether a compound engages its intended targets in a relevant cellular context. This supports more confident candidate prioritization before costly downstream studies.
CellEKT Reaches 100,000th Cell Processing Run
The milestone highlights growing adoption of automated workflows as cell therapy developers seek greater consistency and scalability.
Omivera Launches Strategic Partnership Program to Support Emerging Biotech Companies
A new initiative designed to help biotech startups accelerate growth through expert guidance, strategic support, and industry connections.
Omivera Expands European Operations with New Innovation Hub in Leiden
The new facility strengthens Omivera’s presence in Europe’s life sciences ecosystem and creates new opportunities for research collaboration and innovation.
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!